Delta-Fly Pharma (TSE:4598) Net Margin %: 0.00% (As of Mar. 2026)


TSE:4598 Delta-Fly Pharma Inc TSE:4598
30 GF Score
Price 円135.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma Net Margin %?

Delta-Fly Pharma TSE:4598 +2.27% 30 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 938 Biotechnology companies, Delta-Fly Pharma ranks worse than 106609.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Delta-Fly Pharma's Net Income for the six months ended in Mar. 2026 was 円-784.15 Mil. Delta-Fly Pharma's Revenue for the six months ended in Mar. 2026 was 円0.00 Mil. Therefore, Delta-Fly Pharma's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Delta-Fly Pharma's Net Margin % or its related term are showing as below:


TSE:4598's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.09
* Ranked among companies with meaningful Net Margin % only.

Delta-Fly Pharma  (TSE:4598) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Delta-Fly Pharma Net Margin % Related Terms

Delta-Fly Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma Net Margin % Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -322.43 0.00 0.00 0.00 0.00

Delta-Fly Pharma Semi-Annual Data
Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4598 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Delta-Fly Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delta-Fly Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Delta-Fly Pharma's Net Margin % falls into.


TSE:4598
30GF Score
Delta-Fly Pharma Inc TSE:4598
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delta-Fly Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Delta-Fly Pharma's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-1625.948/0
= %

Delta-Fly Pharma's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-784.148/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Delta-Fly Pharma (TSE:4598) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Delta-Fly Pharma and its competitors. According to the industry distribution chart, Delta-Fly Pharma ranks #999999 out of 938 companies in the Biotechnology industry.
Is Delta-Fly Pharma's Net Margin % too high?
Delta-Fly Pharma's current Net Margin % is 0.00%. Based on the distribution chart, Delta-Fly Pharma ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Delta-Fly Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Delta-Fly Pharma ranks #999999 out of 938 companies for Net Margin %. This places Delta-Fly Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Delta-Fly Pharma and its competitors. Delta-Fly Pharma's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Delta-Fly Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
30GF Score

Get the complete analysis for TSE:4598

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円135.00
Price